期刊文献+

人红白血病细胞株K562培养上清对外周血单个核细胞的影响 被引量:1

The effects of human erythroleukemia cell line K562 supernatant on the peripheral blood mononuclear cells
下载PDF
导出
摘要 目的了解人红白血病细胞株K562分泌物对外周血单个核细胞(PBMC)的影响及其机制。方法选择K562细胞上清处理总的外周血单个核细胞(PBMC),首先用流式细胞术检测K562细胞上清对PBMC活化标志CD69和HLA-DR表达的影响,并通过改良的流式细胞术检测其增殖(数量)情况。然后进一步用流式细胞仪检测PBMC细胞的增殖指数和凋亡率以及各亚群细胞表面标志分子的表达情况。结果在K562细胞上清作用下,PBMC表面活化标志CD69和HLA-DR表达阳性细胞百分率显著增加,但是在K562细胞上清的影响下,PBMC数量明显下降。在检测对照组的增殖指数和凋亡率时,发现在培养72 h后,PBMC细胞的增殖指数明显上升,且凋亡率也显著增加。此外,在进一步对PBMC亚群的检测发现,与对照组相比,T细胞阳性细胞百分率明显下降,B细胞和单核细胞的百分率则显著上升,NK细胞无明显变化。CD4/CD8比值虽有所增加,但变化不明显。结论 K562上清虽能够诱导PBMC细胞活化,但也会诱导亚群中T细胞的大量凋亡,这可能是导致K562逃避免疫监视的原因之一。 We aimed to evaluate the effects of human erythroleukemia cell line K562 supernatant on the peripheral blood mononuclear cells(PBMCs) and investigate the mechanisms.We treated PBMCs were with K562 cell supernatants and set WI-38 cell supernatants as controls.The live PBMC numbers were determined using modified flow cytometry(FCM).Then CD69,HLA-DR,cell cycle,apoptosis,and the molecules expressed on subsets of PBMC surface were detected with flow cytometry after the PBMCs were treated with K562 supernatants for 72 h.we found that K562 cell supernatants dramatically increased the percentage of CD69 positive cells and HLA-DR positive cells,the proliferation index,and the apoptosis,but decreased the number of live PBMCs in a concentration-dependent manner.Furthermore,K562 cell supernatants decreased the T cell subpopulation but increased B cell and monocyte subpopulation in the cultured PBMCs.After K562 cell supernatants treatment,the CD4/CD8 ratio increased slightly but not significantly.Thus,K562 cell supernatants can activate PBMCs and induce apoptosis of T cells,which might be one possible reason for tumor cells to escape from immune surveillance.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第4期322-327,共6页 Immunological Journal
基金 贵州省国际科技合作计划项目([2009]700103) 国家自然科学基金项目(30960443) 人事部留学人员科技活动项目择优资助经费([2009]4)
关键词 K562细胞上清 PBMC 增殖 活化 免疫逃逸 K562 cell supernatant T cell Proliferation Activation Immune escape
  • 相关文献

参考文献21

  • 1吴霞,李大金.肿瘤免疫编辑[J].现代免疫学,2005,25(6):518-521. 被引量:8
  • 2Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape [J]. Nat Immunol, 2002, 3 (11): 991-998.
  • 3Orleans Lindsay JK, Barber LD, Prentice HG, et al. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia [J]. Clin Exp Immunol, 2001, 126 (3): 403-411.
  • 4王兴兵,刘隽,贺艳丽,谷俊侠,郑金娥,姚军霞,杨晶,李小青,黄士昂.急性髓细胞性白血病细胞培养上清对CD4^+和CD8^+ T细胞增殖和凋亡的影响[J].中国实验血液学杂志,2006,14(3):455-459. 被引量:4
  • 5李晓,吕卫国,谢幸,汪辉,叶大风,陈怀增.卵巢癌细胞培养上清抑制CD8^+ T细胞增殖及IL-2R表达的研究[J].中华微生物学和免疫学杂志,2003,23(11):883-886. 被引量:1
  • 6Hirabayashi H, Yasumura S, Lin WC, et al. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells [J]. Arch Otolaryngol Head Neck Surg, 1995, 121 (3): 285-292.
  • 7Wang YY, Zheng XX. A flow cytometry-based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro[J]. J Immunol Methods, 2002, 268 (2): 179-188.
  • 8Zieglera SF, Ramsdell F, Alderson MR. The activation antigen CD69 [J]. Stem Cells, 1994, 12 (5): 456-465.
  • 9Van den Hove LE, Vandenberghe P, Van Gool SW, et al. Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: Evidence for systemic activation of the T cell compartment[J]. Leuk Res, 1998, 22 (2): 175-184.
  • 10张仲苗,戴海斌,周权.铜绿假单胞菌注射液对K562细胞株处理后淋巴细胞凋亡及免疫功能的影响[J].中国药学杂志,2007,42(16):1224-1227. 被引量:8

二级参考文献111

  • 1刘瑞振,张长弓,何琼,苏金华,陈彩霞,陈福,庄国洪.抗人DcR3单克隆抗体的制备、鉴定及应用[J].免疫学杂志,2009(1):34-38. 被引量:8
  • 2Li Hou Ying Li Yong-Hua Jia Bo Wang Yi Xin Mao-Ying Ling Shen Lü Department of Pathology,Dalian Medical University,Dalian 116027,Liaoning Province,ChinaDepartment of Biochemistry,Dalian Medical University,Dalian 116027,Liaoning Province,China.Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice[J].World Journal of Gastroenterology,2001,7(4):532-536. 被引量:47
  • 3Shi-Yong Li, Bo Yu, Ping An, Jia-Chen Wei, Fu-Yi Zuo and Hui-Yun Cai Beijing, China Department of General Surgery, Beijing Military Commend General Hospital, Beijing 100700, China.Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):226-229. 被引量:14
  • 4李昭辉,王占民,赵志伦,张勇.Fas和FasL在胃癌组织中的表达[J].中国现代普通外科进展,2004,7(5):292-293. 被引量:6
  • 5张敏,陈智超,田蕾,刘芳,刘陵波,游泳,邹萍.抗Fas核酶对小鼠T细胞凋亡的抑制作用(英文)[J].癌症,2005,24(5):520-524. 被引量:3
  • 6Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator[J], hnmunity, 2002, 16 (3): 479-92.
  • 7Hayashi S, Miura Y, Nishiyama T, et al. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis [J]. Arthritis Rheum, 2007, 56(4): 1067-1075.
  • 8Pitti RM, Marsters SA, Lawrence DA, el al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer[J]. Nature, 1998, 396(6712): 699-703.
  • 9Chang YC, Hsu TL, Lin HH, et al. Modulation of macrophage differentiation and activation by decoy receptor 3[J]. J Leukoc Biol, 2004, 75 (3): 486-94.
  • 10Hsu TL, Wu YY, Chang YC, et al. Attenuation of Thl response in decoy receptor 3 transgenic mice [J]. J Immunol, 2005, 175 (8): 5135-5145.

共引文献36

同被引文献16

  • 1崔澂,王润田,支国成,王智华,邓郁青,张征峥,佟慧.猪苓多糖下调Colon26细胞肿瘤免疫抑制的体外研究[J].免疫学杂志,2009,25(6):650-654. 被引量:13
  • 2张小梅,伦永志,王仁军,黄敏,曹丽利.黄芪成分F_3新制剂抗肿瘤免疫机理的研究[J].免疫学杂志,2005,21(1):78-78. 被引量:11
  • 3陈玉龙,苗艳艳.肿瘤病机研究思路[J].新中医,2007,39(4):91-92. 被引量:20
  • 4林英城,李德锐,林雯,陈创珍,况丽平,吴晓,洪超群.三氧化二砷对鼻咽癌患者放疗增敏作用与增殖和凋亡相关蛋白关系[J].中国中西医结合杂志,2007,27(8):704-707. 被引量:8
  • 5Liu P, Jaffar J, Zhou Y, et al. Inhibition of tgfbetal makes nonimmunogenic tumor cells effective for therapeutic vaccination[J]. J Immunother, 2009, 32 (3): 232-239.
  • 6Mazzocca A, Fransvea E, Dituri F, et al. Down-regulation of connective tissue gro~h factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma [J]. Hepatology, 2010, 51 (2): 523-534.
  • 7Zhang B, Halder SK, Zhang S, et al. Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer[J]. Cancer Lett, 2009, 277 (1): 114-120.
  • 8Zloza A, Jagoda MC, Lyons GE, et al. CD8 co-receptor promotes susceptibility of CD8+ T ceils to transforming growth factor- [3 (TGF- 13 )-mediated suppression [J]. Cancer Immunol Immunother, 2011, 60 (2): 291-297.
  • 9Zeng P, Zhang Z. Artesunate mitigates proliferation of tumor ceils by alkylating heme-harboring nitric oxide synthase [J]. Nitric Oxide, 2011, 24 (2): 110-112.
  • 10Mazzocca A, Fransvea E, Dituri F, et al. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma [J]. Hepatology, 2010, 51 (2): 523-534.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部